logo

Arcutis Biotherapeutics Inc. (ARQT)



Trade ARQT now with
  Date
  Headline
8/25/2021 8:05:21 AM Arcutis Enrolls First Patient In Phase 3 Clinical Trial Of ARQ-154 As A Potential Treatment For Scalp And Body Psoriasis
8/23/2021 8:12:26 AM Arcutis Biotherapeutics Names Bruce Binkowitz VP Of Biometrics
6/1/2021 7:41:29 AM Arcutis Biotherapeutics Names Rajvir Madan First Chief Digital And Information Officer
2/2/2021 8:54:08 PM Arcutis Biotherapeutics Prices Upsized Public Offering Of 5.50 Mln Shares Of Its Common Stock At $35.00/shr
2/1/2021 7:37:04 AM Arcutis Announces Positive Topline Results From Pivotal DERMIS-1 And -2 Phase 3 Trials Of ARQ-151 In Plaque Psoriasis
6/1/2020 9:17:54 AM Arcutis Biotherapeutics Names Ayisha Jeter VP Of Market Access
5/27/2020 9:18:19 AM Jay Ramsinghani Joins Arcutis As VP Of Commercial Strategy And Operations
4/27/2020 8:36:21 AM Arcutis Biotherapeutics Names Halley Gilbert To Board
3/23/2020 8:56:52 AM Arcutis Biotherapeutics Names Kimberly Lathroum VP Of Marketing
3/5/2020 8:38:01 AM Heather Rowe Armstrong Joins Arcutis As VP Of Investor Relations And Corporate Communications